Biotech Company on Verge of Cancer Breakthrough

Dear National Review Reader, Please find this special message from our sponsoring advertiser, Biotech Research Report. This important support affords us the continuing means to provide you with National Review's distinctly conservative and always exceptional news and commentary. National Review, Inc. Earth Science Tech, Inc. (ETST) is a unique Biotechnology company focused on delivering cutting-edge Nutraceuticals, Bioceuticals and Dietary Supplements designed for excellence in the areas of Health, Wellness, Sports and Alternative Medicine and to Improving the quality of life for Consumers Worldwide. ETST Announces Its New Wholly Owned Subsidiary Leafstrain, Inc. (www.leafstrain.com) a New Online Medical Marijuana & Cannabis Dispensary Locator, Directory and Strain Finder as Well as an Information Community and Social Network. The upside potential with ETST is astronomical. A similar company went from $5.00 a share to over $200.00 a share. ETST has a lot more to offer than that company because it has over 3 different revenue streams. 1. ETST has cornered the Hemp Oil Enriched with CBD market, by buying up 7 figures worth of inventory. 2. ETST is working with University of Central Oklahoma to study the effects of the CBD Oil on cancer cells. 3. ETST currently has 3 products it is selling in the nutraceuticals space; all of them are top sellers in the market. 4. ETST has a brick and mortar presence to sell over 600 products in store, plus another 600 in an online store through its wholly owned subsidiary Nutrition Empire located in Miami, Florida 5. ETST just launched a medical marijuana dispensary locater and strain finder similar to weedmaps.com which has recently gone viral and doing tens of millions of dollars in online advertising revenues. 6. Leafstrain.com is rapidly growing with 3,000 dispensary clients and is expanding exponentially in various corners of the online marketing industry.   Earth Science Tech Announces Positive Preliminary Test Results on the Effects of Its Hemp Oil Enriched With CBD-Cannabidiol on Animal Breast Cancer Cells and on Normal Cells BOCA RATON, FL--(Marketwired - October 09, 2014) - Earth Science Tech, Inc. (ETST) ("ETST" or "the Company"), a unique biotechnology company focused on nutraceuticals, bioceuticals and dietary supplements, announced today that ETST has received an initial report from the Sponsored Research Agreement with the University of Central Oklahoma a public institution of higher education, showing the effects of its Hemp Oil Enriched with CBD-Cannabidiol (provided by Earth Science Tech, Inc.) on animal breast cancer cells and on normal cells. ETST confirmed these preliminary results on its Hemp Oil Enriched with CBD-Cannabidiol and the update regarding the Grant and Study with the University of Central Oklahoma lead investigator Dr. Wei R. Chen have been received. The main points of the report are: A. Objectives This purpose of this experiment is to investigate the effects of Earth Science Tech Hemp oil Enriched with CBD-Cannabidiol on animal breast cancer cells and on normal cells. B. Results B.1. Dose dependence of growth inhibition by Hemp Oil Enriched with CBD-Cannabidiol EMT6 breast cancer cells were incubated with Hemp Oil Enriched with CBD-Cannabidiol of different concentrations (0, 2.5, 5, 10, 25, 50 uM).  B.2. Effects on tumor and normal cells Figure 2 shows that at the effective proprietary dose, Hemp Oil Enriched with CBD-Cannabidiol inhibited the proliferation of cancer cells by nearly 90%, while only inhibited the proliferation of normal cells about 50%. C. Conclusion The results of this preliminary study indicate that with appropriate dose, in this case with its proprietary Hemp Oil Enriched with CBD-Cannabidiol dose, Hemp Oil Enriched with CBD-Cannabidiol can inhibit the proliferation of cancer cells more than that of normal cells. If Hemp Oil Enriched with CBD-Cannabidiol has the same effect in vivo, it may help with cancer patients. However, further experiments are needed to investigate the effects of Hemp Oil Enriched with CBD-Cannabidiol on different cells, particularly on immune cells. CEO of ETST, Harvey Katz, PhD declared: "Our unique position working within the Enhanced Industrial Hemp Oil with CBD field and relationship with the University has already made significant strides on how the Hemp Oil with CBD works. This is just the beginning. These findings are already leading to a better understanding from ETST and the science of unlocking the benefits of Hemp Oil with CBD as well as its true potential. Furthermore I wanted to update the market to let our shareholders know that ETST has begun testing with immune cells. We are excited at what the future may bring us and look forward to keeping the market up to date on our test results and findings. We are here to help the industry and people understand all of the benefits that this amazing natural product produces and will continue to let the public see our reports. Some of the details of the report will remain confidential because ETST looks to file a patent/patents on or before the beginning of November 2014 in regards to its Hemp Oil Enriched with CBD-Cannabidiol." By now nearly everyone has heard of the case of Charlotte Figi, a seven-year-old girl with Dravet Syndrome (a form of severe and intractable epilepsy), who was having as many as 50 seizures a day. In desperation, Charlotte's parents tried everything pharmaceutical science could throw at the problem, even debilitating drugs like barbiturates and benzodiazepines, in an ultimately futile attempt to curb the devastation. The father finally took the leap to try a low-THC (Tetrahydrocannabinol, the psychoactive component), CBD-rich (Cannabidiol) strain of medical marijuana known as Charlotte's Web and since dosing, his daughter has truly thrived, with only two to three seizures per month and a much-improved overall condition. A groundbreaking clinical trial is coming up to study Charlotte's Web in Dravet Syndrome at the University of Colorado and this study's results could provide a real boost to the CBD, as well as broader, medical marijuana markets. The CBD market in particular has been growing by leaps and bounds in recent years, many ailments clearly benefit a great deal from CBD's increasingly apparent pain-relieving, anti-inflammatory, and immunodulatory effects. Industrial hemp is widely known for its low THC levels and comparatively higher levels of CBD, making it an ideal source for developing health and wellness products intended to treat a whole host of conditions, from chronic pain and epilepsy, to diabetes. Even various neurological disorders like ADHD and Parkinson's disease are among the immediate prospects for CBD-rich offerings, according to Project CBD. CBD has even been shown to promote nutritional health in aging people, acting as an antioxidant and neuroprotectant, superbly suited to age-related inflammatory and autoimmune diseases. Pair the 10,000-plus Baby Boomers retiring per day (Pew Research) and Research and Markets' latest report on the U.S. nutraceutical market indicating a projected 6% CAGR through 2017, as the space swells to some $75.3B or more, and you get a perfect storm for CBD nutraceuticals. ETST and College of Mathematics and Science at the University of Central Oklahoma Join Forces in a Joint Effort to Study the Biological and Anti-Tumor Effects of ETST All Natural High Grade CBD (Cannabidiol) Rich Hemp Oil on Cancer Cells Earth Science Tech, Inc. (ETST) ("ETST" or "the Company"), a unique biotechnology company focused on nutraceuticals, bioceuticals and dietary supplements, announced it has joined forces in a combined effort with the College of Mathematics and Science at the University of Central Oklahoma to study the biological and anti-tumor effects of ETST All Natural High Grade CBD (Cannabidiol) Rich Hemp Oil on cancer cells. As previously stated ETST looks to use its High Grade CBD (Cannabidiol) Rich Hemp Oil as a nutritional and dietary supplement to be used for overall health and wellness as well as for various disorders and conditions through upcoming publications, studies and clinical trials. ETST mission is to develop innovative Hemp extracts and to make them accessible worldwide, inform the public on the health benefits of CBD (Cannabidiol) Rich Hemp Oil, to help optimize purity and formulations, and to find new product delivery systems. Cannabidiol (CBD) is a naturally occurring constituent of the Hemp plant. ETST looks to educate consumers on the numerous nutritional benefits of CBD and Hemp oil. ETST is working with industry nutritional and dietary supplement experts in order to spearheadconsumer health and wellness education as well as product development for its CBD Rich Hemp based oil.   The University of Central Oklahoma announced on Friday, September 19th 2014 that Wei R. Chen, Ph.D., assistant dean of the College of Mathematics and Science at the University of Central Oklahoma (UCO), recently received a $10,000 research grant to study the anti-tumor effects of hemp oil. UCO went on to state that the grant is funded by Earth Science Tech, Inc., a Florida-based biotechnology company. Wei R. Chen, Ph.D., a professor of biomedical engineering with more than 20 years of experience in cancer research, will serve as the grant's lead researcher. "I am very excited about the joint effort between UCO and Earth Science Tech to study the biological effects of hemp oil, particularly on cancer cells," said Chen. Hemp oil, a natural product extracted from hemp seeds, is proven to be non-toxic and beneficial to human health. The studies being done with ETST and the UCO will test the effects of High Grade CBD Rich Hemp oil on tumor, normal and immune cells. Chen and a group of research assistants will conduct their research in the Biophotonics Research Laboratory on Central's campus. "This project may lead to new understanding and potential applications of this natural product in cancer research," Chen added. To view the news and article released from the UCO please visit http://broncho2.uco.edu/press/prdetail.asp?NewsID=18081. For more information about the College of Mathematics and Science at Central, visit www.uco.edu/cms. JUNE 24, 2014 by MARCO TORRES Cannabis Oil Cures 8 Month Old Infant of Cancer, Dissolving Large Inoperable Tumor In 8 Months According to Dr. William Courtney, the western medical mind has a very hard if not impossible time trying to understand the diverse actions of Cannabidiol. He explains how his youngest patient who is 8 months old, had a very massive centrally located inoperable brain tumor. The child's father pushed for non-traditional treatment utilizing cannabis and put cannabinoid oil on the baby's pacifier twice per day, gradually increasing the dose. Within two months there was a dramatic reduction. Dr. Courtney pointed out that the success of the cannabis approach means that "this child...is not going to have the long-term side effects that would come from a very high dose of chemotherapy or radiation. This Brain Scan is of the 8-month old baby treated with the CBD Oil now available at www.earthsciencetech.com.     As previously announced, ETST is proud to offer the finest, most natural and consistent High Grade CBD Rich Hemp Oil with no fillers, preservatives or additives. The company's CBD Rich Hemp Oil is made for consumers who want the highest quality natural CBD. ETST High Grade CBD (Cannabidiol) Rich Hemp Oil is natural and formulated using a wide array of cutting-edge technologies such as super critical extraction, isolation, and micron filtration. It is lab tested multiple times during the manufacturing process, from seed to shelf. This also includes being tested for CBD content, other Cannabinoid content, yeast/mold/fungus, and bacteria like E. coli to ensure safety and top quality. Cannabidiol (CBD) is a naturally occurring constituent of the hemp plant (seed, stem and stalk). It is the most abundant non-psychoactive cannabinoid in hemp (cannabis), and is commonly used as a dietary supplement to support general health, immune system support, nervous system and much more. Research shows that many scientists and doctors think the cannabinoids work synergistically to support the whole human endo-cannabinoid system (internal and natural human cannabinoid system). Furthermore, many scientists and doctors believe the endo-cannabinoid system plays a fundamental role in the functioning of many of the major human physiological systems, including the immune and nervous systems.         At market close today, ETST last traded at around a $2.00 a share. How much more upside potential do you need to get at least a little money in your pocket ? And if you think that's out of line, consider what is going to happen with the medical marijuana boom and if it gets legalized. Shareholders made a killing on companies that no one has ever heard of before.   What is CBD Hemp Oil? CBD Hemp Oil is an oil extracted from Industrial Hemp plants (stalks and seeds). The plants used are specially bred to contain high concentrations of the naturally occurring Cannabinoid - Cannabidiol (CBD). It is not psychoactive ie. you absolutely CANNOT get high or intoxicated by consuming CBD Hemp Oil or any natural product from Industrial Hemp plants for that matter. Unlike "Medical Marijuana" it does not contain the psychoactive properties of THC. Additionally, it is well known in scientific research that CBD is anti-psychoactive. ETST is proud to announce the opening of its first retail location in the next 30 to 60 days. The vitamin supplement industry is a multi-billion dollar a year industry and is growing at a rapid pace. ETST looks to capitalize on this and meet those demands in the near future. This location will be the first retail store to sell CBD in the Miami/Dade County. ETST wholly owned subsidiary, Nutrition Empire Inc., and its new upscale retail store location will be located in the heart of Coral Gables Florida at 4585 Ponce DeLeon Blvd., Coral Gables, FL 33146. This location will contain everything needed for health and wellness including but not limited to Sports Nutritional products, dietary supplements and CBD Rich Industrial Hemp products. Nutrition Empire will be a specialty retailer and direct marketer of health, wellness, sports nutrition and dietary supplement products. It operates through 2 segments: Retail and Direct Online. Some of its products will include vitamins, minerals, herbal and dietary supplements, sports nutrition products, homeopathic remedies, green living products, diet products, beauty aids, and other wellness products. Alex Goodyear: Research Analyst, Biotech Research Report Symbol: ETST | Company: Earth Science Tech, Inc.| Quote: http://finance.yahoo.com/q?s=ETST Latest News: http://finance.yahoo.com/q/h?s=ETST+Headlines Company Website: http://www.earthsciencetech.com * Leafstrain is comparable to weedmaps.com, marijuana.com, and leafly.com: these sites do over 1 mm in monthly ad revenue. ** This valuation is based on a price of .25/mg of CBD. *** Current polls show over 60% of all voters approve the MMJ bill in FL. Disclaimer IMPORTANT NOTICE AND DISCLAIMER: This stock profile should be viewed as a paid advertisement. The publisher, Biotech Research Report, understands that in an effort to enhance public awareness of Earth Science Tech, Inc. and its securities through the distribution of this advertisement, Hammock Financial paid all of the costs associated with creating, printing and distribution of this advertisement. The publisher was paid the sum of $11,700 for thier contributions. If successful, this advertisement will increase investor and market awareness, which may result in increased numbers of shareholders owning and trading the common stock of Earth Science Tech, Inc. increased trading volumes, and possibly increased share price of the common stock of Earth Science Tech, Inc. The publisher has not undertaken to determine if Hammock Financial is, or intends to be in the future, directly or indirectly, a shareholder of Earth Science Tech, Inc. The publisher may receive revenue, the amount of which cannot be determined to any degree of certainty, as a result of this advertising effort and the accompanying subscription offer. This publication is not, and should not be construed to be, an offer to sell or a solicitation of an offer to buy any security. This publication, its publisher, and its editor do not purport to provide a complete analysis of any company's financial position. The publisher and editor are not, and do not purport to be, broker-dealers or registered investment advisors. Any investment should be made only after consulting a professional investment advisor and only after reviewing the financial statements and other pertinent corporate information about the company. Further, readers are advised to read and carefully consider the Risk Factors identified and discussed in the advertised company's SEC filings. Investing in securities, particularly micro cap securities such as Earth Science Tech, Inc., is speculative and carries a high degree of risk. Past performance does not guarantee future results. This publication is based exclusively on information generally available to the public and does not contain any material, non-public information. The information on which it is based is believed to be reliable. Nevertheless, the publisher cannot guarantee the accuracy or completeness of the information. This publication contains "forward-looking" statements, including statements regarding expected continual growth of the featured company and/or industry. The publisher notes that statements contained herein that look forward in time, which include everything other than historical information, involve risks and uncertainties that may affect the company's actual results of operations. Factors that could cause actual results to differ include the size and growth of the market for the company's products and services. The company's ability to fund its capital requirements in the near term and long term, pricing pressures, etc is a possible risk factor.  All other trademarks used in this publication are the property of their respective trademark holders.   Manage your National Review subscriptions. We respect your right to privacy. View our policy. This email was sent by: National Review, Inc. 215 Lexington Avenue, 11th Floor New York, NY 10016 4140